390 related articles for article (PubMed ID: 25495656)
1. Cholesterol modulates the interaction of the islet amyloid polypeptide with membranes.
Caillon L; Duma L; Lequin O; Khemtemourian L
Mol Membr Biol; 2014; 31(7-8):239-49. PubMed ID: 25495656
[TBL] [Abstract][Full Text] [Related]
2. Binding of islet amyloid polypeptide to supported lipid bilayers and amyloid aggregation at the membranes.
Sasahara K; Morigaki K; Okazaki T; Hamada D
Biochemistry; 2012 Sep; 51(35):6908-19. PubMed ID: 22876830
[TBL] [Abstract][Full Text] [Related]
3. Amyloid aggregation and deposition of human islet amyloid polypeptide at membrane interfaces.
Sasahara K; Morigaki K; Shinya K
FEBS J; 2014 Jun; 281(11):2597-612. PubMed ID: 24702784
[TBL] [Abstract][Full Text] [Related]
4. Molecular Structure, Membrane Interactions, and Toxicity of the Islet Amyloid Polypeptide in Type 2 Diabetes Mellitus.
Caillon L; Hoffmann AR; Botz A; Khemtemourian L
J Diabetes Res; 2016; 2016():5639875. PubMed ID: 26636105
[TBL] [Abstract][Full Text] [Related]
5. The N-terminal fragment of human islet amyloid polypeptide is non-fibrillogenic in the presence of membranes and does not cause leakage of bilayers of physiologically relevant lipid composition.
Khemtémourian L; Engel MF; Liskamp RM; Höppener JW; Killian JA
Biochim Biophys Acta; 2010 Sep; 1798(9):1805-11. PubMed ID: 20570648
[TBL] [Abstract][Full Text] [Related]
6. Conformational Dynamics of the Human Islet Amyloid Polypeptide in a Membrane Environment: Toward the Aggregation Prone Form.
Skeby KK; Andersen OJ; Pogorelov TV; Tajkhorshid E; Schiøtt B
Biochemistry; 2016 Apr; 55(13):2031-42. PubMed ID: 26953503
[TBL] [Abstract][Full Text] [Related]
7. Impaired processing of human pro-islet amyloid polypeptide is not a causative factor for fibril formation or membrane damage in vitro.
Khemtémourian L; Lahoz Casarramona G; Suylen DP; Hackeng TM; Meeldijk JD; de Kruijff B; Höppener JW; Killian JA
Biochemistry; 2009 Nov; 48(46):10918-25. PubMed ID: 19817482
[TBL] [Abstract][Full Text] [Related]
8. Interplay between human islet amyloid polypeptide aggregates and micro-heterogeneous membranes.
Tan Q; Liu H; Duan M; Huo S
Biochim Biophys Acta Biomembr; 2021 Nov; 1863(11):183691. PubMed ID: 34224702
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of hypoglycemic agents to target human islet amyloid polypeptide: a key protein involved in amyloid deposition and beta-cell loss.
Fortin JS; Benoit-Biancamano MO
Can J Diabetes; 2015 Oct; 39(5):373-82. PubMed ID: 25862064
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms for the destabilization of model membranes by islet amyloid polypeptide.
Divakara MB; Martinez D; Ravi A; Bhavana V; Ramana V; Habenstein B; Loquet A; Santosh MS
Biophys Chem; 2019 Feb; 245():34-40. PubMed ID: 30576976
[TBL] [Abstract][Full Text] [Related]
11. Human IAPP amyloidogenic properties and pancreatic β-cell death.
Fernández MS
Cell Calcium; 2014 Nov; 56(5):416-27. PubMed ID: 25224501
[TBL] [Abstract][Full Text] [Related]
12. Islet amyloid polypeptide: aggregation and fibrillogenesis in vitro and its inhibition.
Seeliger J; Winter R
Subcell Biochem; 2012; 65():185-209. PubMed ID: 23225004
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the effects of two major secretory granules components, insulin and zinc, on human-IAPP amyloid aggregation and membrane damage.
Khemtemourian L; Antoniciello F; Sahoo BR; Decossas M; Lecomte S; Ramamoorthy A
Chem Phys Lipids; 2021 Jul; 237():105083. PubMed ID: 33887213
[TBL] [Abstract][Full Text] [Related]
14. Low pH acts as inhibitor of membrane damage induced by human islet amyloid polypeptide.
Khemtémourian L; Doménech E; Doux JP; Koorengevel MC; Killian JA
J Am Chem Soc; 2011 Oct; 133(39):15598-604. PubMed ID: 21870807
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the Role of the Conserved Disulfide in Amyloid Formation by Human Islet Amyloid Polypeptide in Homogeneous and Heterogeneous Environments.
Ridgway Z; Zhang X; Wong AG; Abedini A; Schmidt AM; Raleigh DP
Biochemistry; 2018 May; 57(21):3065-3074. PubMed ID: 29697253
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation.
Caillon L; Lequin O; Khemtémourian L
Biochim Biophys Acta; 2013 Sep; 1828(9):2091-8. PubMed ID: 23707907
[TBL] [Abstract][Full Text] [Related]
17. Environmental factors differently affect human and rat IAPP: conformational preferences and membrane interactions of IAPP17-29 peptide derivatives.
Pappalardo G; Milardi D; Magrì A; Attanasio F; Impellizzeri G; La Rosa C; Grasso D; Rizzarelli E
Chemistry; 2007; 13(36):10204-15. PubMed ID: 17902185
[TBL] [Abstract][Full Text] [Related]
18. Interaction of hIAPP with model raft membranes and pancreatic beta-cells: cytotoxicity of hIAPP oligomers.
Weise K; Radovan D; Gohlke A; Opitz N; Winter R
Chembiochem; 2010 Jun; 11(9):1280-90. PubMed ID: 20440729
[TBL] [Abstract][Full Text] [Related]
19. Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane.
Engel MF; Khemtémourian L; Kleijer CC; Meeldijk HJ; Jacobs J; Verkleij AJ; de Kruijff B; Killian JA; Höppener JW
Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6033-8. PubMed ID: 18408164
[TBL] [Abstract][Full Text] [Related]
20. ABCA1 deficiency and cellular cholesterol accumulation increases islet amyloidogenesis in mice.
Wijesekara N; Kaur A; Westwell-Roper C; Nackiewicz D; Soukhatcheva G; Hayden MR; Verchere CB
Diabetologia; 2016 Jun; 59(6):1242-6. PubMed ID: 26970755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
